A detailed history of Legal & General Group PLC transactions in Axogen, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 94,761 shares of AXGN stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,761
Previous 94,761 -0.0%
Holding current value
$1.58 Million
Previous $1.33 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $14.69 $657,932 - $1.29 Million
-87,491 Reduced 48.01%
94,761 $1.33 Million
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $300,226 - $426,777
52,950 Added 40.95%
182,252 $1.32 Million
Q1 2024

May 14, 2024

BUY
$6.63 - $10.69 $167,016 - $269,291
25,191 Added 24.2%
129,302 $1.04 Million
Q4 2023

Feb 15, 2024

SELL
$3.61 - $7.76 $292,680 - $629,142
-81,075 Reduced 43.78%
104,111 $711,000
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $154,477 - $305,654
33,008 Added 21.69%
185,186 $925,000
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $1.14 Million - $1.4 Million
134,520 Added 761.81%
152,178 $1.39 Million
Q1 2023

May 15, 2023

SELL
$7.53 - $10.95 $652,926 - $949,474
-86,710 Reduced 83.08%
17,658 $166,000
Q4 2022

Feb 14, 2023

SELL
$9.44 - $13.09 $58,490 - $81,105
-6,196 Reduced 5.6%
104,368 $1.04 Million
Q3 2022

Nov 14, 2022

SELL
$8.14 - $12.25 $110,297 - $165,987
-13,550 Reduced 10.92%
110,564 $1.32 Million
Q2 2022

Aug 22, 2022

SELL
$6.99 - $10.0 $929,341 - $1.33 Million
-132,953 Reduced 51.72%
124,114 $1.02 Million
Q1 2022

May 16, 2022

SELL
$7.26 - $10.7 $367,820 - $542,104
-50,664 Reduced 16.46%
257,067 $2.04 Million
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $883,511 - $1.61 Million
100,399 Added 48.42%
307,731 $2.88 Million
Q3 2021

Nov 15, 2021

BUY
$15.23 - $21.72 $612,520 - $873,534
40,218 Added 24.07%
207,332 $3.28 Million
Q2 2021

Aug 12, 2021

BUY
$17.8 - $23.5 $128,569 - $169,740
7,223 Added 4.52%
167,114 $3.61 Million
Q1 2021

May 17, 2021

BUY
$17.18 - $22.6 $1.18 Million - $1.55 Million
68,575 Added 75.1%
159,891 $3.24 Million
Q4 2020

Feb 12, 2021

BUY
$11.5 - $17.96 $232,081 - $362,450
20,181 Added 28.37%
91,316 $1.63 Million
Q3 2020

Nov 13, 2020

BUY
$10.62 - $13.12 $81,646 - $100,866
7,688 Added 12.12%
71,135 $827,000
Q2 2020

Aug 14, 2020

BUY
$7.35 - $10.81 $220,860 - $324,829
30,049 Added 89.97%
63,447 $586,000
Q1 2020

May 14, 2020

BUY
$8.38 - $17.34 $102,160 - $211,391
12,191 Added 57.49%
33,398 $445,000
Q4 2019

Feb 13, 2020

BUY
$11.18 - $18.6 $16,714 - $27,807
1,495 Added 7.58%
21,207 $379,000
Q3 2019

Nov 13, 2019

BUY
$12.09 - $20.46 $53,328 - $90,249
4,411 Added 28.83%
19,712 $243,000
Q2 2019

Aug 14, 2019

BUY
$18.5 - $25.47 $45,787 - $63,038
2,475 Added 19.3%
15,301 $303,000
Q4 2018

Feb 15, 2019

BUY
$17.09 - $38.25 $11,997 - $26,851
702 Added 5.79%
12,826 $262,000
Q3 2018

Nov 20, 2018

BUY
$34.05 - $55.9 $232,357 - $381,461
6,824 Added 128.75%
12,124 $447,000
Q2 2018

Aug 10, 2018

SELL
$36.15 - $52.5 $1,952 - $2,835
-54 Reduced 1.01%
5,300 $266,000
Q1 2018

May 17, 2018

SELL
$24.4 - $40.25 $27,767 - $45,804
-1,138 Reduced 17.53%
5,354 $195,000
Q4 2017

Feb 13, 2018

BUY
$18.5 - $28.6 $120,102 - $185,671
6,492
6,492 $184,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $704M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.